Nuclear Radiology: Page 49

Ipsen bids for OctreoPharm
By AuntMinnieEurope.com staff writers
French biotechnology firm Ipsen has inked an agreement to purchase German radiopharmaceutical developer OctreoPharm Sciences for a total price of up to 50 million euros ($55.7 million U.S.).
May 19, 2015
Novel PET/CT tracer helps detect prostate cancer recurrence
By AuntMinnieEurope.com staff writers
German researchers are reporting early success in performing PET/CT with a novel gallium-68-labeled prostate-specific membrane antigen ligand to detect prostate cancer recurrence after radical prostatectomy.
May 5, 2015
Report: Nuclear medicine market to hit $2.2B by 2020
By AuntMinnieEurope.com staff writers
The worldwide nuclear medicine imaging market for PET and SPECT equipment is on track to produce $2.2 billion in revenues by 2020, according to a new report by RnR Market Research.
April 30, 2015
AAA reports sales boost in 2014
By AuntMinnieEurope.com staff writers
Sales growth coupled with clinical progress for its products helped buoy molecular imaging firm Advanced Accelerator Applications (AAA) to higher financial ground in 2014.
April 9, 2015
Global nuclear medicine market set to grow
By AuntMinnieEurope.com staff writers
Analysts forecast that the global nuclear imaging market will grow at a compound annual growth rate of 5.9% from 2014 to 2019.
March 15, 2015
MILabs completes Belgian installation
By AuntMinnieEurope.com staff writers
MILabs has installed its new PET/SPECT/CT/MRI platform at the In Vivo Cellular and Molecular Imaging Lab at the University Brussels Belgium.
March 10, 2015
PET/MRI effectively diagnoses foot pain
By AuntMinnieEurope.com staff writers
PET/MRI can diagnose the cause of foot pain better than other imaging modalities, with the added benefit of less radiation exposure for patients.
March 9, 2015
The big question: CT, MRI, or nuclear for coronary artery disease diagnosis?
By Becky McCall
Faced with a choice of CT, MRI, and hybrid nuclear imaging for the diagnosis of coronary artery disease, which modality is most suitable for any one patient type and why? All three play an important role in the diagnostic process, according to speakers at a presentation on Saturday at ECR 2015.
March 6, 2015
2015 03 06 17 42 29 18 2015 03 07 Cad1 20150307004610
Video from ECR 2015: Thomas Beyer, PhD, on hybrid imaging
VIENNA - What does the future hold for PET/MRI? Can it ever be cost-effective? Thomas Beyer, PhD, a professor at the Medical University of Vienna, answers these questions in an interview with AuntMinnieEurope.com Editor-in-Chief Philip Ward at ECR 2015.
March 5, 2015
2015 03 06 10 37 36 539 2015 03 06 Ecr Video Beyer
Video from ECR 2015: Thomas Beyer, PhD, on hybrid imaging
What does the future hold for PET/MRI? Can it ever be cost-effective? Thomas Beyer, PhD, a professor at the Medical University of Vienna, answers these questions in an interview with AuntMinnieEurope.com Editor-in-Chief Philip Ward at ECR 2015.
March 4, 2015
Hybrid techniques make giant strides in clinical practice
By Frances Rylands-Monk
As hybrid imaging gains more ground in cardiology, neurology, and oncology, the debate over PET/MRI's current and potential role in routine practice still rages. The central question remains: Is it an expensive new toy with no clinical applications on the horizon, or is it a truly revolutionary technique?
March 3, 2015
2015 02 26 13 13 14 983 2015 03 04 Ecr Today Antoch Esophageal Cancer Post Therapy 20150226201338
Mediso, Tübingen partner on preclinical PET/MRI
By AuntMinnieEurope.com staff writers
Nuclear imaging firm Mediso Medical Imaging Systems and the University of Tübingen have entered into a collaboration to develop a whole-body preclinical PET insert based on silicon photomultiplier sensor technology.
February 23, 2015
Previous Page
Page 49 of 90
Next Page